<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-SP2TIYN6/20a1e697-9707-469a-89a0-a04e976f4ca2/PDF"><dcterms:extent>80 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-SP2TIYN6/d10d7fa3-8df4-40fe-9f78-2e330493d1e5/TEXT"><dcterms:extent>37 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-SP2TIYN6"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>1998</dcterms:issued><dc:creator>Rebolj Stare, Marija</dc:creator><dc:creator>Toff, Renata</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:37</dc:format><dc:format xml:lang="sl">str. 367-379</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:9229529</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-SP2TIYN6</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">drug</dc:subject><dc:subject xml:lang="en">Drug therapy</dc:subject><dc:subject xml:lang="en">Epidemiology</dc:subject><dc:subject xml:lang="en">Etiology</dc:subject><dc:subject xml:lang="en">Infant mortality</dc:subject><dc:subject xml:lang="en">Infant, newborn</dc:subject><dc:subject xml:lang="en">Infant, premature</dc:subject><dc:subject xml:lang="en">Labor, premature</dc:subject><dc:subject xml:lang="en">Magnesium sulfate</dc:subject><dc:subject xml:lang="sl">nedonošenčki</dc:subject><dc:subject xml:lang="en">Nitric oxide</dc:subject><dc:subject xml:lang="en">Pregnancy</dc:subject><dc:subject xml:lang="sl">preprečevanje</dc:subject><dc:subject xml:lang="sl">prezgodnji porod</dc:subject><dc:subject xml:lang="en">Ritodrine</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="en">Tocolysis</dc:subject><dc:subject xml:lang="en">Tocolytic agents</dc:subject><dc:subject xml:lang="sl">vzroki</dc:subject><dc:subject xml:lang="sl">zdravila</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q835884" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Grozeč prezgodnji porod in zdravljenje| Threatened preterm delivery and therapy|</dc:title><dc:description xml:lang="sl">Preterm delivery is still one of the main causes contributing a great deal to the perinatal morbidity and mortality. Preterm birth of the child can be postponed, or at least we can try to postpone it, with tocolysis. Time gained is used for maternal aplication of corticosteroids, which enhances maturation of fetal lungs and formation of surtactant. Morbidity and mortality of the preterm newborns are thus lowered. Beta agonist ritodrine and magnesium sulphate are the most commonly used tocolytics in Department of perinatology. In the article threatened preterm delivery and newer tocolytics, as well as those used in the past, are discussed</dc:description><dc:description xml:lang="sl">Prezgodnji porod je eden glavnih dejavnikov, ki v veliki meri prispevajo k perinatalni obolevnosti in umrljivosti. Prezgodnje rojstvo otroka lahko odložimo oz. poskušamo odložiti s tokolizo. Pridobljeni čas podaljšane nosečnosti uporabimo za dajanje kortikosteroidov materi, kar pospeši zorenje plodovih pljuč in nastajanje surfaktanta. S tem se zmanjša obolevnost in umrljivost prezgodaj rojenih otrok. Kot tokolitika se na Kliničnem oddelku za perinatologijo Ginekološke klinike Ljubljana najpogosteje uporabljata agonist beta ritodrin in magnezijev sulfat. V članku so obravnavani tudi novejši tokolitiki oz. tisti, ki so se nekdaj uporabljali</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-SP2TIYN6"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-SP2TIYN6" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-SP2TIYN6/20a1e697-9707-469a-89a0-a04e976f4ca2/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-SP2TIYN6/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-SP2TIYN6" /></ore:Aggregation></rdf:RDF>